Lupin informs about press release

05 Jun 2024 Evaluate
Lupin has enclosed a Press Release as regards completion of acquisition by Lupin Atlantis Holdings SA, Switzerland, wholly owned subsidiary of the Company, of two well-known brands, AaraneTM in Germany and NalcromTM in Canada and the Netherlands, along with the associated trademark rights, from Sanofi. This disclosure pursuant to Regulation 30 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2144.50 7.35 (0.34%)
27-Jan-2026 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.45
Dr. Reddys Lab 1239.60
Cipla 1313.70
Zydus Lifesciences 889.75
Lupin 2144.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×